bit.ly
Parkinson disease is a fatty acidopathy
Nature Reviews Neurology, Published online: 01 October 2025; doi:10.1038/s41582-025-01142-2This Perspective centres on alterations in the fatty acid-ome as the critical feature of lipid aberration in α-synucleinopathies, specifically Parkinson disease. Here, the authors explain the biological and genetic basis for their hypothesis, with an emphasis on the transient binding of α-synuclein to fatty acids of various lipids.